
Loading, please wait...

Loading, please wait...

Single-row and double-row repair remain widely used approaches for arthroscopic rotator cuff surgery. This meta-analysis of randomized trials examined whether the choice of repair construct changes patient outcomes and tendon integrity. Across the included studies, standard functional scores such as the ASES, Constant and UCLA scales often did not differ substantially between techniques. However, imaging-based outcomes consistently favoured double-row repair, with lower structural re-tear rates and better tendon healing. This creates an important clinical nuance: a more anatomically robust repair does not necessarily produce a dramatic difference in short-term patient-reported function, particularly in smaller tears. The choice of construct should therefore consider tear size, tissue quality, tendon retraction, footprint restoration and surgeon experience rather than relying on a single universal rule. The study supports double-row or suture-bridge strategies when structural healing is a priority, especially in larger or more complex tears, while recognising that increased construct complexity and cost may not translate into large gains for every patient. For HCPs, the key point is to separate two goals—symptom and functional improvement versus structural integrity—and decide how much each matters in the individual surgical context.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Single-row and double-row repair remain widely used approaches for arthroscopic rotator cuff surgery. This meta-analysis of randomized trials examined whether the choice of repair construct changes patient outcomes and tendon integrity. Across the included studies, standard functional scores such as the ASES, Constant and UCLA scales often did not differ substantially between techniques. However, imaging-based outcomes consistently favoured double-row repair, with lower structural re-tear rates and better tendon healing. This creates an important clinical nuance: a more anatomically robust repair does not necessarily produce a dramatic difference in short-term patient-reported function, particularly in smaller tears. The choice of construct should therefore consider tear size, tissue quality, tendon retraction, footprint restoration and surgeon experience rather than relying on a single universal rule. The study supports double-row or suture-bridge strategies when structural healing is a priority, especially in larger or more complex tears, while recognising that increased construct complexity and cost may not translate into large gains for every patient. For HCPs, the key point is to separate two goals—symptom and functional improvement versus structural integrity—and decide how much each matters in the individual surgical context.
Today

The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back

A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back

Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back

A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back